doi: 10.1016/j.jacc.2023.04.052 7 MalikRATesfayeSZieglerD
1B, upper right image) to an extent comparable to that of the control cells (green, Fig
The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds
CrossRef Association of common variant rs9934336 of SLC5A2 (SGLT2) gene with SARS-CoV-2 infection and mortality Anamika Das, Gunanidhi Dhangadamajhi Egyptian Journal of Medical Human Genetics.2024;[Epub] CrossRef Mathematical Models of the Effect of Glucagon on Glycemia in Individuals With Type 2 Diabetes Treated With Dapagliflozin Tomoko Yamada, Hikaru Sugimoto, Ken-ichi Hironaka, Yasuko Morita, Hiroshi Miura, Natsu Otowa-Suematsu, Yuko Okada, Yushi Hirota, Kazuhiko Sakaguchi, Shinya Kuroda, Wataru Ogawa Journal of the Endocrine Society.2024;[Epub] CrossRef -hydroxybutyrate as a biomarker of -cell function in new-onset type 2 diabetes and its association with treatment response at 6 months Minyoung Lee, Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee Diabetes & Metabolism.2023
Up to 30% of PD patients also have Dupuytrens
